Sword Bio is a bioanalytical contract research organization (CRO) that focuses on assay development, validation, and sample analysis. The company provides services such as pharmacokinetics, immunogenicity, and biomarker analysis for drug discovery and clinical trials. Sword Bio mainly works with biotech and pharmaceutical companies on their bioanalytical needs. Sword Bio was formerly known as Sword Diagnostics, Inc.. It was founded in 2004 and is based in Chicago, Illinois.

Cira Discovery Sciences, Inc. was founded in 2003 and funded by BioAdvance in 2004 with the mission of discovering biomarker patterns for medical diagnostic products and drug discovery services. The company targets two key application domains, proteomics and flow cytometry, both utilized in the diagnostic and pharmaceutical fields. Cira has developed and patented methods of computational analysis of large, high-dimensionality data sets characteristic of both proteomics and flow cytometry. Advances in these fields are currently hampered by limitations in extracting valuable patentable knowledge from the data. The company ceased operations in 2008 and its intellectual property is being marketed for acquisition.

Promega is a company in the life sciences sector, focusing on the development of products and technologies for biochemical and molecular biology applications. Their main offerings include a range of biological reagents and reagent systems for research and applied technology, as well as instrumentation and services that aid scientific work. Promega's products are utilized in various fields such as academic research, industrial applications, and government institutions for purposes including disease diagnosis, therapeutic discovery, and human identification through DNA testing. It was founded in 1978 and is based in Madison, Washington.

The scientists at Genomic Solutions have a wealth of genomic, protein analysis and nano-liter dispensing application-based expertise that they would like to share with users. First select their area of research, followed by interest and then application, and finally, to the company's instrumentation which can help facilitate their research. Whether users are involved in the life science or biotechnology research community, the company's products will enable users to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. You achieve rapid and less expensive drug discovery.

Nanion Technologies GmbH specializes in providing electrophysiological instrumentation and scientific support within the life sciences sector. The company offers a range of automated patch clamp systems and in vitro technologies for ion channel and transporter research, membrane biophysics, and cell analytics. These tools are utilized for drug discovery and assay development in academic, pharmaceutical, and CRO environments. It was founded in 2002 and is based in Germany.

NanoBioDesign (NBD) offers a range of P450 assays to assist drug discovery